Blood testing
Sponsors
Naito Yoshiki, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Calgary
Conditions
Breast cancer, Pancreatobiliary cancer, Lung cancer, Head and neck cancer
Cancer, Breast cancer, Pancreatobiliary cancer, Lung cancer, Head and Neck cancerCOVID-19 PandemicCancerDiabetesDiabetes Mellitus, Type 2Endocrine System DiseasesHIVHIV Infection
Phase 1
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
CompletedNCT00001644
Start: 1997-03-03End: 2010-02-17Updated: 2017-07-02
Metabolism of Nicotine and Cotinine in Pregnant African-American Women
CompletedNCT00341640
Start: 2005-01-06End: 2006-12-01Target: 50Updated: 2017-07-02
Family Management of Childhood Diabetes Study
CompletedNCT00340938
Start: 2004-11-08End: 2009-08-20Updated: 2019-12-17
Phase 2
Phase 4
Unknown Phase
Assessment of Cardiac Involvement of Common Cold in High Performing Athletes by Cardiac Magnetic Resonance Imaging (MRI)
TerminatedNCT00739895
Start: 2007-06-30End: 2011-09-30Target: 100Updated: 2011-10-04
Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients
NCT01918501
Start: 2013-08-31End: 2015-07-31Target: 120Updated: 2013-12-03
Predictors of Time to Viremia With an Analytic Treatment Interruption
WithdrawnNCT03033017
Start: 2016-07-31End: 2019-01-31Updated: 2017-12-04
Biomarkers of Immune-Related Toxicity
Active, not recruitingNCT03409016
Start: 2018-04-18End: 2026-05-28Target: 69Updated: 2025-09-05
Hormonal Contributors to COVID-19 Infection (COV-ENDO)
CompletedNCT05749770
Start: 2020-05-01End: 2024-06-30Updated: 2025-09-02
Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland
TerminatedNCT05787457
Start: 2014-07-31End: 2021-09-30Updated: 2023-03-28
Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis
RecruitingNCT07012915
Start: 2025-07-01End: 2026-12-31Target: 100Updated: 2025-07-10